Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

46.16

+0.14 (0.30%)

At close: Mar 6, 2026, 4:00 PM EST

46.16

0.00 (0.00%)

After-hours: Mar 6, 2026, 5:08 PM EST

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	165.6	183.58	107.95	122.72	122.47
Short-Term Investments	248.48	60.05	98.42	67.89	59.73
Cash & Short-Term Investments	414.07	243.63	206.37	190.61	182.2
Cash Growth	69.96%	18.05%	8.27%	4.61%	-43.68%
Accounts Receivable	15.59	41.72	21.27	12.66	3.99
Other Receivables	-	-	-	7.66	-
Total Trade Receivables	15.59	41.72	21.27	20.32	3.99
Inventory	54.9	26.36	31.12	21.6	3.68
Other Current Assets	42.61	20.08	17.54	10.54	6.59
Total Current Assets	527.18	331.8	276.3	243.06	196.45
Net Property, Plant & Equipment	11.75	11.04	12.67	7.04	8.38
Other Intangible Assets	15.25	16.25	17.25	18.25	19.25
Other Long-Term Assets	209.46	221.47	220.11	191.32	8.72
Total Assets	763.63	580.55	526.32	459.67	232.8
Accounts Payable	2.03	2.04	8.25	7.9	1.87
Accrued Expenses	112.04	80.51	44.67	30.11	38.03
Current Portion of Leases	2.99	1.99	2.25	3.3	3.38
Unearned Revenue	-	-	0.31	-	-
Other Current Liabilities	22.13	16.08	8.19	5.75	1.54
Total Current Liabilities	139.18	100.62	63.67	47.07	44.82
Long-Term Leases	6.51	7.86	10.01	2.62	2.67
Other Long-Term Liabilities	50.33	33.63	13.81	13.84	0.27
Total Long-Term Liabilities	56.84	41.5	23.82	16.46	2.94
Total Liabilities	196.03	142.12	87.48	63.52	47.76
Common Stock	0.02	0.02	0	0.02	0.02
Additional Paid-in Capital	1,030	959.72	916.76	888.12	860.48
Accumulated Other Comprehensive Income	-0.03	-0.16	0.01	0.04	-0.07
Retained Earnings	-462.14	-521.14	-477.95	-492.03	-675.4
Shareholders' Equity	567.61	438.44	438.84	396.15	185.04
Total Liabilities & Equity	763.63	580.55	526.32	459.67	232.8
Total Debt	9.5	9.86	12.26	5.92	6.05
Net Cash (Debt)	404.58	233.77	194.11	184.69	176.15
Net Cash Growth	73.06%	20.43%	5.10%	4.85%	-44.34%
Net Cash Per Share	5.12	3.27	2.70	2.62	2.57
Book Value	567.61	438.44	438.84	396.15	185.04
Book Value Per Share	7.19	6.14	6.10	5.63	2.70
Tangible Book Value	552.36	422.19	421.59	377.9	165.79
Tangible Book Value Per Share	6.99	5.91	5.86	5.37	2.42

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q